Dosing strategies for switching from oral risperidone to paliperidone palmitate: Effects on clinical outcomes

INTRODUCTION: There are currently no guidelines for switching patients from oral risperidone to paliperidone palmitate (Invega Sustenna®). Furthermore, the paliperidone long-acting injectable (LAI) package insert does not recommend bridging with oral antipsychotics, which may result in inadequate se...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ment Health Clin
Hauptverfasser: Hsia, Stephanie L., Leckband, Susan G., Rao, Sanjai, Jackson, Elizabeth, Lacro, Jonathan P.
Format: Artigo
Sprache:Inglês
Veröffentlicht: College of Psychiatric & Neurologic Pharmacists 2018
Schlagworte:
Innovative Practices
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6007563/
https://ncbi.nlm.nih.gov/pubmed/29955505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2017.05.095
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge